MultiplexDX Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $8.31M

  • Investors
  • 10

MultiplexDX General Information

Description

Manufacturer of diagnostics kits intended to eliminate cancer misdiagnosis by launching accurate, quantitative, and accessible diagnostic tests. The company's services combine the approach of molecular biology and histopathological methods for the treatment of tumors and cancer, enabling oncology patients to return to their normal lives and ensure proper diagnosis by offering highly specialized custom oligonucleotides to the research community.

Contact Information

Website
www.multiplexdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Research Court
  • Suite 450
  • Rockville, MD 20850
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Manufacturing, Digital Health, TMT, HealthTech, Life Sciences, Oncology
Corporate Office
  • One Research Court
  • Suite 450
  • Rockville, MD 20850
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MultiplexDX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 15-Oct-2024 $8.31M Completed Generating Revenue
7. Grant 09-Oct-2019 Completed Generating Revenue
6. Accelerator/Incubator 10-Jun-2019 Completed Generating Revenue
5. Equity Crowdfunding 15-Nov-2018 Completed Generating Revenue
4. Grant 01-Oct-2018 Completed Generating Revenue
3. Accelerator/Incubator 30-Sep-2018 Completed Generating Revenue
2. Grant 11-Dec-2016 $47.5K $16.4K Completed Generating Revenue
1. Seed Round 10-Jan-2016 $16.4K $16.4K Completed Generating Revenue
To view MultiplexDX’s complete valuation and funding history, request access »

MultiplexDX Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed III
Seed II
Seed I 400,000 $0.000100 8% $0.98 $0.98 1x $0.98 30.42%
To view MultiplexDX’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MultiplexDX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of diagnostics kits intended to eliminate cancer misdiagnosis by launching accurate, quantitative, and acce
Diagnostic Equipment
Rockville, MD
36 As of 2023

Irvine, CA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MultiplexDX Competitors (4)

One of MultiplexDX’s 4 competitors is Agendia, a Venture Capital-Backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agendia Venture Capital-Backed Irvine, CA
Advanced Cell Diagnostics Formerly VC-backed Minneapolis, MN
TriLink BioTechnologies Private Equity-Backed San Diego, CA
Qiagen Formerly VC-backed Hilden, Germany
To view MultiplexDX’s complete competitors history, request access »

MultiplexDX Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

MultiplexDX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024390388-A1 Method for predicting the efficacy of an antibody-drug-conjugate (adc) using multiplex fluorescence in situ hybridization (fish) and multiplex sequencing Pending 01-Dec-2023
EP-4816550-A1 Method for predicting the efficacy of an antibody-drug-conjugate (adc) using multiplex fluorescence in situ hybridization (fish) and multiplex sequencing Pending 01-Dec-2023
WO-2025114609-A1 Method for predicting the efficacy of an antibody-drug-conjugate (adc) using multiplex fluorescence in situ hybridization (fish) and multiplex sequencing Inactive 01-Dec-2023
US-20240026435-A1 Loop mediated isothermal nucleic acid amplification (lamp) using lna-modified primers and a metal-based colorimetric method for detecting an amplification product Pending 02-Dec-2020
AU-2021378475-A1 Loop mediated isothermal nucleic acid amplification (lamp) using lna-modified primers and a metal-based colorimetric method for detecting an amplification product Pending 10-Nov-2020 C12Q1/6853
To view MultiplexDX’s complete patent history, request access »

MultiplexDX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MultiplexDX Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lumus Investment Angel Group Minority
Venture to Future Fund Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
Invest Horizon Accelerator/Incubator
Crowdberry VC-Backed Company Minority
You’re viewing 5 of 10 investors. Get the full list »

MultiplexDX Investments (1)

MultiplexDX’s most recent deal was a Seed Round with StratifAI for . The deal was made on 02-Sep-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
StratifAI 02-Sep-2024 Seed Round Diagnostic Equipment
To view MultiplexDX’s complete investments history, request access »

Ready to get started?

Request a free trial

MultiplexDX FAQs

  • When was MultiplexDX founded?

    MultiplexDX was founded in 2015.

  • Where is MultiplexDX headquartered?

    MultiplexDX is headquartered in Rockville, MD.

  • What is the size of MultiplexDX?

    MultiplexDX has 36 total employees.

  • What industry is MultiplexDX in?

    MultiplexDX’s primary industry is Diagnostic Equipment.

  • Is MultiplexDX a private or public company?

    MultiplexDX is a Private company.

  • What is MultiplexDX’s current revenue?

    The current revenue for MultiplexDX is .

  • How much funding has MultiplexDX raised over time?

    MultiplexDX has raised $9.6M.

  • Who are MultiplexDX’s investors?

    Lumus Investment, Venture to Future Fund, European Innovation Council, Invest Horizon, and Crowdberry are 5 of 10 investors who have invested in MultiplexDX.

  • Who are MultiplexDX’s competitors?

    Agendia, Advanced Cell Diagnostics, TriLink BioTechnologies, and Qiagen are competitors of MultiplexDX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process